Blood test could predict metastasis risk in melanoma

Scientists at Yale University have identified a set of plasma biomarkers that could reasonably predict the risk of metastasis among patients with melanoma, according to findings published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Read the whole article on Physorg

More from Physorg